JP2018515442A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515442A5
JP2018515442A5 JP2017552910A JP2017552910A JP2018515442A5 JP 2018515442 A5 JP2018515442 A5 JP 2018515442A5 JP 2017552910 A JP2017552910 A JP 2017552910A JP 2017552910 A JP2017552910 A JP 2017552910A JP 2018515442 A5 JP2018515442 A5 JP 2018515442A5
Authority
JP
Japan
Prior art keywords
flt
composition
antibody
binding fragment
antigen binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017552910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515442A (ja
JP6797826B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/026420 external-priority patent/WO2016164567A1/en
Publication of JP2018515442A publication Critical patent/JP2018515442A/ja
Publication of JP2018515442A5 publication Critical patent/JP2018515442A5/ja
Application granted granted Critical
Publication of JP6797826B2 publication Critical patent/JP6797826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017552910A 2015-04-07 2016-04-07 気管支肺異形成症の治療における抗Flt−1抗体 Active JP6797826B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562144241P 2015-04-07 2015-04-07
US62/144,241 2015-04-07
PCT/US2016/026420 WO2016164567A1 (en) 2015-04-07 2016-04-07 Anti-flt-1 antibodies in treating bronchopulmonary dysplasia

Publications (3)

Publication Number Publication Date
JP2018515442A JP2018515442A (ja) 2018-06-14
JP2018515442A5 true JP2018515442A5 (https=) 2019-05-16
JP6797826B2 JP6797826B2 (ja) 2020-12-09

Family

ID=55969453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017552910A Active JP6797826B2 (ja) 2015-04-07 2016-04-07 気管支肺異形成症の治療における抗Flt−1抗体

Country Status (10)

Country Link
US (2) US10738123B2 (https=)
EP (1) EP3280737B1 (https=)
JP (1) JP6797826B2 (https=)
CN (1) CN107690335A (https=)
AU (1) AU2016246730B2 (https=)
BR (1) BR112017021413A2 (https=)
HK (1) HK1249908A1 (https=)
MA (1) MA41908A (https=)
MX (2) MX391847B (https=)
WO (1) WO2016164567A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385370B (es) * 2016-03-31 2025-03-18 Immutrix Therapeutics Inc Metodo para el tratamiento extracorporeo de preeclampsia y trastornos relacionados.
CN113260628A (zh) * 2018-06-22 2021-08-13 夏尔人类遗传性治疗公司 治疗支气管肺发育不良的抗flt-1抗体
EP3936054A1 (en) * 2020-07-08 2022-01-12 Assistance Publique - Hôpitaux de Paris Method of prognosis of bronchopulmonary dysplasia in premature infants
KR20240046239A (ko) * 2021-08-16 2024-04-08 얀센 바이오테크 인코포레이티드 항-vegfr1 항체 및 이들의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
KR101215701B1 (ko) 2002-07-19 2012-12-26 베스 이스라엘 데코니스 메디칼 센터 자간전증 또는 자간의 진단 및 치료 방법
US7335362B2 (en) * 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
CN101102791B (zh) 2004-11-18 2011-12-14 英克隆有限责任公司 抗血管内皮生长因子受体-1的抗体
US20060153835A1 (en) * 2005-01-12 2006-07-13 Smith Henry J Treatment of pre-eclampsia in pregnant women using targeted apheresis
US8349325B2 (en) * 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
EP2672996B1 (en) * 2011-02-07 2018-07-04 Aggamin LLC Methods and systems for treating or preventing pregnancy-related hypertensive disorders
ES2676406T3 (es) * 2013-01-28 2018-07-19 Shire Human Genetic Therapies, Inc. Anticuerpos anti-Flt-1 en el tratamiento de la distrofia muscular de Duchenne
TW201517916A (zh) 2013-03-15 2015-05-16 Lilly Co Eli Vegfr1抗體之治療用途

Similar Documents

Publication Publication Date Title
JP2022050618A5 (https=)
JP2018515442A5 (https=)
CN113527485B (zh) 抗人白细胞介素-4受体α抗体及其制备方法和应用
EP3983439A1 (en) Use of an activatable anti-pdl1 antibody and an anti-ctla-4 antibody in a combination therapy for the treatment of cancer
JP2009541374A5 (https=)
RU2017120437A (ru) Способы лечения хронического синусита с полипами носа путем введения антагониста il-4r
JP2020512281A5 (https=)
JP2010520290A5 (https=)
JP2017507139A5 (https=)
JP2017507652A5 (https=)
JP2011506483A5 (https=)
JP2009533367A5 (https=)
JP2021526534A5 (https=)
JP2019513726A5 (https=)
EP3347054A1 (en) Dosing regimens for anti-tf-antibody drug-conjugates
JP2021509668A (ja) 免疫抑制なしにil−6媒介性炎症を処置する方法
JP2013508292A5 (https=)
JP2017507945A5 (https=)
JP2016511234A5 (https=)
JP2019513748A5 (https=)
JP2020504135A5 (https=)
JP2023517611A5 (https=)
JP2025508867A5 (https=)
AU2021400979A1 (en) Combination therapy for the treatment of cancer
JP2018517667A5 (https=)